Timo Purmonen, Head of Data Driven Business and Market AccessA professional and forward-looking business partner, Oriola provides valuable insights and support to its clients’ strategic decision-making and innovation throughout a product’s lifecycle. Through its high-quality distribution and expert services, the company empowers pharmaceutical companies to succeed in the Nordic countries.
Its expertise in health and wellbeing allows Oriola to offer a wide range of services for pharmaceutical companies, including regulatory affairs, medical affairs, market access and tenders, HEOR and RWE, clinical trial services, distribution and warehousing, pharmacovigilance and medical information, as well as sales and marketing.
“In response to the changing business environment, we continuously develop our operations and services to exceed customer needs and expectations,” says Timo Purmonen, Head of data-driven business and market access.
Oriola’s market access services are designed to help clients navigate the complex landscape of pricing and reimbursement, hospital tenders, health technology assessment (HTA) processes and risk-sharing agreements.
From reference price notifications to conditional reimbursement negotiations, the company provides clients with comprehensive support. Leveraging its versatile pharmaceutical and health economic expertise, the firm offers market access and hospital tender services to ensure patients get access to new treatment without unnecessary delay. Its proficiency in risk-sharing agreements further assists clients in achieving favorable outcomes and successful market entry.
Oriola’s team of experts possesses comprehensive knowledge of real-world evidence (RWE), providing clients with tools for fact-based decision-making. The team has built a method to combine real-world data (RWD) and patient-reported outcomes (PRO) without compromising data security. RWD is sourced from national registers, hospital data lakes and private healthcare providers, including electronic medical records. PRO, on the other hand, is obtained through the firm’s country-wide Research pharmacy network and patient organisations. Consequently, through a data-driven approach to success, Oriola offers comprehensive market insights and research services to support clients’ market entry and commercial activities.
The company acknowledges the significance of knowing the market; thus, health economics and landscape analysis are often leveraged to support clients’ strategies for market access. Oriola empowers clients with comprehensive health economics analysis and insights, enabling them to navigate the HTA process and gain a profound market understanding. Its data-driven approach enables clients to effortlessly access the market, delivering tangible results.
In response to the changing business environment, we continuously develop our operations and services to exceed customer needs and expectations
The company’s commitment to excellence is rooted in its scientific approach and unwavering dedication to quality. Collaborating with renowned experts who specialises in post-doctoral research, pharmacoepidemiology, register studies, data science, HEOR and hospital data lakes, Oriola diligently strives to uphold exceptional service standards. By combining scientific expertise with local market knowledge, Oriola delivers tailored solutions that meet clients’ diverse needs. Using its in-depth understanding of business opportunities and pitfalls regarding market and hospital access in the Nordic healthcare sector, Oriola continues to shape the future of pharmaceutical distribution and contribute to the sustainable development of society.
Orion and Oriola to continue partnership in Finland
Wednesday, October 11, 2023
Orion and Oriola are renewing their distribution agreement in Finland. According to the agreement, Oriola will continue to provide warehousing and distribution services for Orion’s human and veterinary pharmaceuticals in Finland. The new agreement was signed on 29 June 2023, and is effective from 1 July 2024.
The close cooperation of the two Finnish companies will continue to secure quality and timely distribution of pharmaceuticals to the Finnish healthcare sector.
“I’m very pleased with the continuation of our partnership. Oriola and Orion have a long history of working together. As companies we share mutual ambition in enhancing the wellbeing of people, animals and society, as well as strong commitment in promoting sustainability in our operations. This requires strong collaboration in the changing healthcare environment,” says Katarina Gabrielson, CEO of Oriola.
“We are happy to continue our long term cooperation with Oriola in ensuring high-quality delivery services to our customers,” says Janne Maksimainen, Head of Region Finland & Baltics at Orion.
Oriola Partners With HCLTech to Enhance Customer Experience Through Digital Transformation
Thursday, March 28, 2024
ESPOO - HCLTech, a global technology company, announced that it has been selected by Oriola Corporation, a leading health and wellbeing company operating in the Nordic region, to accelerate Oriola’s digital transformation journey and deliver enhanced customer experiences.
HCLTech will implement a greenfield SAP S/4HANA and analytics environment hosted on Microsoft Azure to transform Oriola’s enterprise resource planning (ERP) and enterprise warehouse management (EWM) systems in Sweden and Finland.
The solution will leverage RISE with SAP delivering an end-to-end global experience platform (GxP)-compliant and validated solution for Oriola. Moving to an agile, cloud-based ERP platform will allow Oriola to transform and simplify their business operations, enabling them to modernize the application stack and optimize IT operating costs.
“This strategically important project will allow Oriola to better respond to future customer and business needs, strengthen collaboration across the company, improve transparency and support managing the business in a cross-market operating model. Through a common system, we will strengthen our processes and have access to common data, both of which will support us in serving our customers better,” said Mikael Nurmi, Chief Digital Officer, Oriola.
“We look forward to accelerating Oriola’s business transformation with our strong partnership with SAP and innovative product engineering capabilities,” said Pankaj Tagra, Corporate Vice President, Europe and Africa, HCLTech. “We are delighted to participate in Oriola’s journey to becoming a forerunner in the advanced distribution of pharmaceuticals and in providing advisory services to pharmaceutical companies throughout product lifecycles, while further growing our business in the Nordics region and across the life sciences and pharma sector globally.”
HCLTech is an SAP Global Strategic Services Partner with over 25 years of experience in leading complex SAP transformation programs. HCLTech’s SAP consultant base has now grown to over 10,000 globally, with local offices and consultants across the Americas, Europe, Asia and Africa.
